Xiaoling Li
At Pacific Since: 1993
Xiaoling Li, PhD earned a bachelor of science in pharmacy in 1982 and a master of science in nuclear pharmacy in 1985 from Shanghai First Medical College in China. In 1991 Dr. Li received his doctor of philosophy in pharmaceutics from University of Utah. He also completed two years of post-doctoral training at Ciba-Geigy Corporation, now known as Novartis.
In 2012, Dr. Li received the highest award bestowed on a Pacific faculty member, the University Distinguished Faculty award. Dr. Li has published total of 111 research papers, review articles and chapters, three books as well as more than 190 abstracts. He is active member of the Association of American Pharmaceutical Scientists (AAPS), the Controlled Release Society, the American Chinese Pharmaceutical Association and the Sino-American Pharmaceutical Association.
During his time at Pacific he has mentored and trained 27 PhD, 4 MS, 16 post-doctoral research fellows and 18 visiting scientists. He loves the positive teaching and research environment at Pacific where faculty can interact with a diverse group of professional students and graduate students. During his tenure at Pacific, he served as department chair, graduate program director and associate dean of research and graduate education.
He is a Fellow of both AAPS and the American Institute for Medical and Biological Engineering. In 2015, Dr. Li was a recipient of AAPS Outstanding Educator Award, which recognizes individuals “who have made extensive contributions to the teaching of pharmaceutical sciences.”
BS in Pharmacy, Shanghai Medical University, 1982
MS in Nuclear Pharmacy, Shanghai Medical University, 1985
PhD in Pharmaceutics, University of Utah, 1991
PostDoc, Ciba-Geigy Corporation (Novartis)
Teaching Philosophy
“It takes effort and hard work to excel in learning.”
Courses
PHAR 117 — Principles and Application of Dosage Forms
PCSP 224 — Diffusion in Pharmaceutical Sciences
PCSP 287/387 — Internship
PCSP 297/397 — Graduate Research
PCSP 299 — Thesis Research
PCSP 399 — Dissertation Research
Research Interests
- Antibody mimics
- Peptide-drug conjugates
- Cancer targeted drug delivery
- Transbuccal/sublingual drug delivery
- Solubility and solubility enhancement
- Mechanisms of drug permeation through biological membranes
- Design and synthesis of novel polymers for pharmaceutical applications
Scholarly Activity
Sameer Sachdeva, Hyun Joo, Jerry Tsai, Bhaskara Jasti, Xiaoling Li. A Rational Approach for Creating Peptides Mimicking Antibody Binding. Nature Scientific Reports 9, Article number:997 (2019).
Yu Zheng ’13, PhD, Feihuang Deng, Bo Wang, Yue Wu, Qing Luo, Xianghao Zuo, Xin Liu ’13, PhD, Lihua Cao, Min Li, Haohui Lu, Senping Cheng, Xiaoling Li, PhD published “Melt extrusion deposition (MED™) 3D printing technology – A paradigm shift in design and development of modified release drug products” in the International Journal of Pharmaceutics, June 1, 2021.
Timothy Tracy, Lei Wu, Xin Liu’13, Senping Cheng, Xiaoling Li. 3D Printing: Innovative Solutions for Patients and Pharmaceutical Industry. International Journal of Pharmaceutics 631: 122480, 2023.